TBI Overview2020-02-26T19:50:32+00:00


BioDirection exhibiting at this year’s 2019 MEDICA Conference in Düsseldorf, Germany

BioDirection is excited to be exhibiting at this year’s 2019 MEDICA Conference in Düsseldorf, Germany!

Please visit us on November 18th – 21st in Hall 3, Booth C36-4 to learn more about BioDirection’s Tbit™ System that uses a hand-held analyzer and single-use cartridge to deliver real-time, point-of-care diagnosis of traumatic brain injury in 90 seconds from a single drop of blood. The BioDirection Tbit™ System is currently for investigational use only. Visit us online at http://biodirection.com/

About BioDirection®, Inc.

BioDirection® is a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and management of concussion and other traumatic brain injury (TBI). The company’s lead product, the NanoDxTM System, delivers biologically based results shown to accurately confirm a concussion in less than 2 minutes. BioDirection’s platform utilizes a patented nano biosensor technology with the potential for use in a wide range of applications in point-of-care diagnostics. To learn more about BioDirection, visit http://www.biodirection.com

Anthony Tremaglio
Vice President of Global Marketing
Tel: +1 617.440.4488
Email: ttremaglio@biodirection.com

Sharad Joshi, President & CEO
BioDirection d/b/a/ NanoDx™ and Nanodiagnostics™
Tel: +1 508.599.2400
Email: sharad@biodirection.com